Page 866 - Williams Hematology ( PDFDrive )

840 Part VI: The Erythrocyte Chapter 54: Hemolytic Anemia Resulting from Immune Injury 841

20. Sokol RJ, Hewitt S, Stamps BK: Autoimmune haemolysis: An 18-year study of 865 cases 57. Bengtsson U, Staffan A, Aurell M, Kaijser B: Antazoline-induced immune hemolytic
referred to a regional transfusion centre. Br Med J 282:2023, 1981. anemia, hemoglobinuria and acute renal failure. Acta Med Scand 198:223, 1975.
21. Sokol RJ, Hewitt S, Stamps BK: Autoimmune haemolysis: Mixed warm and cold anti- 58. Habibi B, Basty R, Chodez S, Prunat A: Thiopental-related immune hemolytic anemia
body type. Acta Haematol 69:266, 1983. and renal failure. N Engl J Med 312:353, 1985.
22. Shulman IA, Branch DR, Nelson JM, et al: Autoimmune hemolytic anemias with both 59. Squires JE, Mintz PD, Clark S: Tolmetin-induced hemolysis. Transfusion 25:410,
cold and warm autoantibodies. JAMA 253:1746, 1985. 1985.
23. Kajii E, Miura Y, Ikemoto S: Characterization of autoantibodies in mixed-type autoim- 60. Sosler SD, Behzad V, Garratty G, et al: Immune hemolytic anemia associated with
mune hemolytical anemia. Vox Sang 60:45, 1991. probenecid. Am J Clin Pathol 84:391, 1985.
24. Berentsen S, Bo K, Shammas F, et al: Chronic cold agglutinin disease of the “idiopathic” 61. Salama A, Mueller-Eckhardt C: Two types of nomifensine-induced immune haemolytic
type is a premalignant or low-grade malignant lymphoproliferative disease. APMIS anaemias: Drug-dependent sensitization and/or auto-immunization. Br J Haematol
105:354, 1997. 64:613, 1986.
25. Telen MJ, Roberts KB, Bartlett JA: HIV-associated autoimmune hemolytic anemia: 62. Habibi B, Cartron JP, Bretagne M, et al: Anti-nomifensine antibody causing immune
Report of a case and review of the literature. J Acquir Immune Defic Syndr 3:933, 1990. hemolytic anemia and renal failure. Vox Sang 40:79, 1981.
26. Rapoport AP, Rowe JM, McMican A: Life-threatening autoimmune hemolytic anemia 63. Fulton JD, Briggs JD, Dominiczak AF, et al: Intravascular haemolysis and acute renal
in patient with acquired immune deficiency syndrome. Transfusion 28:190, 1988. failure induced by nomifensine. Scott Med J 31:242, 1986.
27. Saif M: HIV Associated autoimmune hemolytic anemia: An update. AIDS Patient Care 64. Garratty G, Postoway N, Schwellenbach J, McMahill PC: A fatal case of ceftriaxone
15:217, 2001. (Rocephin)-induced hemolytic anemia associated with intravascular immune hemoly-
28. VanArsdel PP Jr, Gilliland BC: Anemia secondary to penicillin treatment: Studies on sis. Transfusion 31:176, 1991.
two patients with non-allergic serum hemagglutinins. J Lab Clin Med 65:277, 1965. 65. Rosenfeld CS, Winters SJ, Tedrow HE: Diethylstilbestrol-associated hemolytic anemia
29. Petz LD, Fudenberg HH: Coombs-positive hemolytic anemia caused by penicillin with a positive direct antiglobulin test result. Am J Med 86:617, 1989.
administration. N Engl J Med 274:171, 1966. 66. Salama A, Burger M, Mueller-Eckhardt C: Acute immune hemolysis induced by a deg-
30. Swanson MA, Chanmougan D, Schwartz RS: Immuno-hemolytic anemia due to antip- radation product of amphotericin B. Blut 58:59, 1989.
enicillin antibodies. N Engl J Med 274:178, 1966. 67. Wolf B, Conradty M, Grohmann R, et al: A case of immune complex hemolytic anemia,
31. Levine B, Redmond A: Immunochemical mechanisms of penicillin-induced Coombs thrombocytopenia, and acute renal failure associated with doxepin use. J Clin Psychia-
positivity and hemolytic anemia in man. Int Arch Allergy Appl Immunol 1:594, 1967. try 50:99, 1989.
32. White JM, Brown DL, Hepner GW, Worlledge SM: Penicillin-induced hemolytic 68. Salama A, Kroll H, Wittmann G, Mueller-Eckhardt C: Diclofenac-induced immune
anaemia. Br Med J 3:26, 1968. haemolytic anaemia: Simultaneous occurrence of red blood cell autoantibodies and
33. Seldon MR, Bain B, Johnson CA, Lennox CS: Ticarcillin-induced immune haemolytic drug-dependent antibodies. Br J Haematol 95:640, 1996.
anaemia. Scand J Haematol 28:459, 1982. 69. Bougie D, Johnson ST, Weitekamp LA, Aster RH: Sensitivity to metabolite of diclofenac
34. Tuffs L, Manoharan A: Flucloxacillin-induced haemolytic anaemia. Med J Aust 144:559, as a cause of acute immune hemolytic anemia. Blood 90:407, 1997.
1986. 70. Cunha PD, Lord RS, Johnson ST, et al: Immune hemolytic anemia caused by sensitivity
35. Gralnick HR, McGinnis MH, Elton W, McCurdy P: Hemolytic anemia associated with to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug. Transfusion 40:663,
cephalothin. JAMA 217:1193, 1971. 2000.
36. Branch DR, Berkowitz LR, Becker RL, et al: Extravascular hemolysis following the 71. Park GM, Han KS, Chang YH, et al: Immune hemolytic anemia after treatment with
administration of cefamandole. Am J Hematol 18:213, 1985. pemetrexed for lung cancer. J Thorac Oncol 3:196 2008.
37. Chambers LA, Donovan BA, Kruskall MS: Ceftazidime-induced hemolysis patient with 72. Mayer B, Leo A, Herziger A, et al: Intravascular hemolysis caused by the contrast
drug-dependent antibodies reactive by immune complex and drug adsorption mecha- medium iomeprol. Transfusion 53:2141, 2013.
nisms. Am J Clin Pathol 95:393, 1991. 73. Carstairs KC, Breckenridge A, Dollery CT, Worlledge SM: Incidence of a positive direct
38. Gallagher NI, Schergen AK, Sokol-Anderson ML, et al: Severe immune-mediated Coombs test in patients on alpha-methyldopa. Lancet 2:133, 1966.
hemolytic anemia secondary to treatment with cefotetan. Transfusion 32:266, 1992. 74. Worlledge SM, Carstairs KC, Dacie JV: Autoimmune haemolytic anaemia associated
39. Garratty G, Nance S, Lloyd M, Domen R: Fatal immune hemolytic anemia due to cefo- with α-methyldopa therapy. Lancet 2:135, 1966.
tetan. Transfusion 32:269, 1992. 75. Breckenridge A, Dollery CT, Worlledge SM, et al: Positive direct Coombs tests and
40. Wenz B, Klein RL, Lalezari P: Tetracycline-induced immune hemolytic anemia. Trans- antinuclear factors in patients treated with methyldopa. Lancet 2:1265, 1967.
fusion 14:265, 1974. 76. Lo Buglio AF, Jandl JH: The nature of alpha-methyldopa red cell antibody. N Engl J Med
41. Simpson MB, Pryzbylik J, Innis B, Denham MA: Hemolytic anemia after tetracycline 276:658, 1967.
therapy. N Engl J Med 312:840, 1985. 77. Cotzias GC, Papavasiliou PS: Autoimmunity in patients treated with levodopa. JAMA
42. Pujol M, Fernandez F, Sancho JM, et al: Immune hemolytic anemia induced by 6-mer- 207:1353, 1969.
captopurine. Transfusion 40:75, 2000. 78. Henry RE, Goldberg LS, Sturgeon P, Ansel RD: Serologic abnormalities associated with
43. Steanini M, Johnson NL: Positive antihuman globulin test in patients receiving carbro- l-dopa therapy. Vox Sang 20:306, 1971.
mal. Am J Med Sci 259:49, 1970. 79. Joseph C: Occurrence of positive Coombs test in patients treated with levodopa. N Engl
44. Bird GWG, Ecles GH, Litchfield JA, et al: Haemolytic anaemia associated with antibod- J Med 286:1400, 1972.
ies to tolbutamide and phenacetin. Br Med J 1:728, 1972. 80. Gabor EP, Goldberg LS: Levodopa-induced Coombs positive haemolytic anaemia.
45. Malacarne P, Castaldi G, Bertusi M, Zavagli G: Tolbutamide-induced hemolytic ane- Scand J Haematol 11:201, 1973.
mia. Diabetes 26:156, 1977. 81. Territo MC, Peters RW, Tanaka KR: Autoimmune hemolytic anemia due to levodopa
46. Salama A, Mueller-Eckhardt C: Cianidanol and its metabolites bind tightly to red cells therapy. JAMA 226:1347, 1973.
and are responsible for the production of auto- and/or drug-dependent antibodies 82. Scott GL, Myles AB, Bacon PA: Autoimmune haemolytic anaemia and mefenamic acid
against these cells. Br J Haematol 66:263, 1987. therapy. Br Med J 3:543, 1968.
47. Martinengo M, Ardenghi DF, Tripodi G, Reali G: The first case of drug-induced 83. Robertson JH, Kennedy CC, Hill CM: Haemolytic anaemia associated with mefenamic
immune hemolytic anemia due to hydrocortisone. Transfusion 48:1925, 2008. acid. Ir J Med Sci 140:226, 1971.
48. Arndt P, Garratty G, Isaak E, et al: Positive direct and indirect antiglobulin tests asso- 84. Habibi B: Drug-induced red blood cell autoantibodies co-developed with drug-specific
ciated with oxaliplatin can be due to drug antibody and or drug-induced nonimmuno- antibodies causing a hemolytic anaemia. Br J Haematol 61:139, 1985.
logic protein adsorption. Transfusion 49:711, 2009. 85. Kleinman S, Nelson R, Smith L, Goldfinger D: Positive direct antiglobulin tests and
49. Arndt PA, Garratty G, Brasfield FM, et al: Immune hemolytic anemia due to cimeti- immune hemolytic anemia in patients receiving procainamide. N Engl J Med 311:809,
dine: The first example of a cimetidine antibody. Transfusion 50:302, 2010. 1984.
50. Muirhead EE, Halden ER, Groves M: Drug-dependent Coombs (antiglobulin) test and 86. Kramer MR, Levene C, Hershko C: Severe reversible autoimmune haemolytic anaemia
anemia: Observations on quinine and acetophenetidin (phenacetin). Arch Intern Med and thrombocytopenia associated with diclofenac therapy. Scand J Haematol 36:118,
101:827, 1958. 1986.
51. Croft JD Jr, Swisher SN, Gilliland BC, et al: Coombs test positivity induced by drugs: 87. Byrd JC, Hertler AA, Weiss RB, et al: Fatal recurrence of autoimmune hemolytic ane-
Mechanisms of immunologic reactions and red cell destruction. Ann Intern Med mia following pentostatin therapy in a patient with a history of fludarabine-associated
68:176, 1968. hemolytic anemia. Ann Oncol 6:300, 1995.
52. Freedman AL, Barr PS, Brody E: Hemolytic anemia due to quinidine: Observations on 88. Weiss R, Freiman J, Kweder S, et al: Hemolytic anemia after fludarabine therapy for
its mechanism. Am J Med 20:806, 1956. chronic lymphocytic leukemia. J Clin Oncol 16:1885, 1998.
53. Logue GL, Boyd AE, Rosse WF: Chlorpropamide-induced immune hemolytic anemia. 89. Garratty, G: Immune hemolytic anemia associated with drug therapy. Blood Rev 24:143,
N Engl J Med 283:900, 1970. 2010.
54. Kopicky JA, Packman CH: The mechanisms of sulfonylurea-induced immune hemoly- 90. Chasty RC, Myint H, Oscier DG, et al: Autoimmune haemolysis in patients with B-CLL
sis. Case report and review of the literature. Am J Hematol 23:283, 1986. treated with chlorodeoxyadenosine (CDA). Leuk Lymphoma 29:391, 1998.
55. Kashyap AS, Kashyap S: Hemolytic anemia due to metformin. Postgrad Med J 76:125, 2000. 91. Kwan JM, Reese AM, Trafeli JP: Delayed autoimmune hemolytic anemia in efalizumab-
56. Pereira A, Sanz C, Cervantes F, Castillo R: Immune hemolytic anemia and renal failure treated psoriasis. J Am Acad Dermatol 58:1053, 2008.
associated with rifampicin-dependent antibodies with anti-I specificity. Ann Hematol 92. Darabi K, Kantamnei S, Weirnik PH: Lenalidomide-induced warm autoimmune hemo-
63:56, 1991. lytic anemia. J Clin Oncol 24:e59, 2006.

Kaushansky_chapter 54_p0823-0846.indd 841 9/19/15 12:28 AM